ArticleJournal of experimental pharmacology2025
An Agonist of Zinc-Sensing G-Protein Coupled Receptor 39 Accelerates Skin Wound Healing and Protects Against UVB-Induced Keratinocyte Damage.
Article in Journal of experimental pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Enhanced expression of spinal PTP1B contributes to peripheral inflammation- induced glycinergic disinhibition and mechanical pain.Communications biology · 2026Article
- GPCRs as key regulators in wound healing.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Keratinocytes establishes skin barrier integrity. Wound and ultraviolet B (UVB)-induced keratinocyte damage mainly contributes to the disruption of skin barrier properties. Recently, we found that pharmacological activation of zinc-sensing G-protein coupled receptor 39 (GPR39) promotes keratinocyte proliferation. Here, we further investigated the effects of TC-G 1008, a synthetic GPR39 agonist, on skin wound healing and UVB-induced keratinocyte damage. Methods: Scratch assay was used as a cell-based wound healing model. UVB exposure was performed to induce oxidative stress and cell death. BrdU incorporative assay was used to assess the rate of keratinocyte proliferation. MTT assay and Hoechst33342/ethidium homodimer-1 co-staining assay were used to evaluate cell viability and apoptosis, respectively. Western blot analysis was performed to investigate protein expression of AMP-activated protein kinase (AMPK) and extracellular signal-regulated kinase (ERK) phosphorylation. Sirtuin-1 (SIRT-1) activity assay and DCFDA assay were used to investigate SIRT-1 activity and to measure levels of intracellular reactive oxygen species (ROS). Results: We found that TC-G 1008 (up to 10 µM) dose-dependently enhanced the wound healing rate in a keratinocyte-like HaCaT cell line in a cell proliferation-independent manner. TC-G1008 reduced apoptosis and ROS production following UVB exposure. Notably, GPR39 agonism-induced wound healing and its protective effects against UVB-induced keratinocyte damage were abrogated by co-treatment with inhibitors of intracellular signaling, including protein kinase A (PKA), AMPK, sirtuin-1 (SIRT-1), and ERK. TC-G 1008 treatment induced AMPK phosphorylation via a PKA-dependent mechanism and promoted ERK phosphorylation by stimulating the AMPK/SIRT-1 pathway. In addition, TC-G 1008 treatment enzymatically activated SIRT-1 and this effect was suppressed by pretreatment with an AMPK inhibitor. Discussion and conclusion: Collectively, activation of GPR39 promoted wound healing and protected keratinocytes from UVB exposure via PKA/AMPK/SIRT-1/ERK-dependent mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.